ArticleNature communications2020

PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma.

Xian-De Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.